Ionis Pharma (IONS) Highlights Top-Line Data from Phase 1/2 Study of ONIS-HTTRx (RG6042) at AAN Meetings
Tweet Send to a Friend
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today presented top-line data from the Phase 1/2 study of IONIS-HTTRx (RG6042) in people with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
